In PLoS Medicine Basu et al report on a systematic meta-analytic comparison of private and public health care systems in low- and middle-income countries such as Viet Nam, Namibia, Tanzania, Sri Lanka, Bangladesh, India and
The Awl–which I totally and unabashedly love–has a piece on the over-promise and under-delivery of personal genomics. It’s a familiar meme and probably not news to Genomeboy readers (both of you!) that a fair number
About a month ago I implored you to donate to The Rare Genomics Institute, which is an organization that is not trafficking in airy-fairy promises about what genomics can do for you or your executive
Introduction and Part I here. You have criticized your own institution, the University of Minnesota, in print, for being involved in a dubious drug trial in which a patient died. I can imagine that doing
In 2009 I attended the annual meeting of the American Society for Bioethics and Humanities. The keynote speaker was Carl Elliott. I knew he was a Professor at the Center for Bioethics at the University
I think those of us (yes, I’m looking in the mirror) who complain loudly when an article we want to read is trapped behind a pay wall have an obligation to call attention to our
In my book, I wrote: For decades, medical genetics has been criticized as a field akin to bird-watching, whose credo is “diagnose and adios.” That’s still true…and even the “diagnose” part is too often elusive.
Thanks again to the immortal Rebecca Skloot for the tweet chat! I thought I’d do it again by roping in another kick-ass nonfiction writer who’s looking at science and its place in the larger world.
The other day I met an endocrinologist (no, this is not the setup for a bad hormone joke). She described the nervousness among her colleagues when they receive Facebook friend requests from their patients. The